International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Cannabis Incannex partners with Curia to accelerate production of IHL-216A New inhalable drug containing CBD designed for efficacious treatment of brain injuries Rowan DunneAugust 2, 2022
Business MediPharm Labs sells Australian facility for $6.2M In July last year, the company received a pharmaceutical Drug Establishment License from Health Canada Natalia Buendia CalvilloJuly 12, 2022
Business Allied Corp. finishes exporting the first Colombia-grown flower shipment to international markets The company has other 4 exports planned for Australia, Switzerland and United States. Natalia Buendia CalvilloJune 29, 2022
Cannabis Tetra Bio-Pharma enters Australia via new subsidiary acquisition Canadian company set to focus clinical trials down under, announces regulatory update Rowan DunneJune 6, 2022
Business Allied Corp. to send €1M of cannabis to Australian partner The company is awaiting approval of an import permit Natalia Buendia CalvilloFebruary 7, 2022
International Australia wants medical cannabis importers to follow GMP standards Currently, Australian producers must comply with GMP standards but there isn't the same requirement for foreign firms Kathryn TindaleJanuary 28, 2022
International Australia switches to single licence for medical cannabis companies Most licences will be issued without a fixed end date Kathryn TindaleDecember 28, 2021